These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 10883672

  • 1. Modulation of paclitaxel resistance by annexin IV in human cancer cell lines.
    Han EK, Tahir SK, Cherian SP, Collins N, Ng SC.
    Br J Cancer; 2000 Jul; 83(1):83-8. PubMed ID: 10883672
    [Abstract] [Full Text] [Related]

  • 2. Paclitaxel triggers cell death primarily via caspase-independent routes in the non-small cell lung cancer cell line NCI-H460.
    Huisman C, Ferreira CG, Bröker LE, Rodriguez JA, Smit EF, Postmus PE, Kruyt FA, Giaccone G.
    Clin Cancer Res; 2002 Feb; 8(2):596-606. PubMed ID: 11839682
    [Abstract] [Full Text] [Related]

  • 3. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A, Soprano DR, Parekh HK.
    Cancer Res; 2001 Oct 15; 61(20):7552-5. PubMed ID: 11606393
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK, Han EK, Credo B, Jae HS, Pietenpol JA, Scatena CD, Wu-Wong JR, Frost D, Sham H, Rosenberg SH, Ng SC.
    Cancer Res; 2001 Jul 15; 61(14):5480-5. PubMed ID: 11454695
    [Abstract] [Full Text] [Related]

  • 13. The establishment of two paclitaxel-resistant prostate cancer cell lines and the mechanisms of paclitaxel resistance with two cell lines.
    Takeda M, Mizokami A, Mamiya K, Li YQ, Zhang J, Keller ET, Namiki M.
    Prostate; 2007 Jun 15; 67(9):955-67. PubMed ID: 17440963
    [Abstract] [Full Text] [Related]

  • 14. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Gan PP, Pasquier E, Kavallaris M.
    Cancer Res; 2007 Oct 01; 67(19):9356-63. PubMed ID: 17909044
    [Abstract] [Full Text] [Related]

  • 15. Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
    Yoshida M, Matsui Y, Ikarashi Y, Usui T, Osada H, Wakasugi H.
    Anticancer Res; 2007 Oct 01; 27(2):729-36. PubMed ID: 17465195
    [Abstract] [Full Text] [Related]

  • 16. The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells.
    Lin JC, Chang SY, Hsieh DS, Lee CF, Yu DS.
    Oncol Rep; 2005 May 01; 13(5):983-8. PubMed ID: 15809768
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Augmentation of ethanol-induced cell damage and activation of nuclear factor-kappa B by annexin IV in cultured cells.
    Sohma H, Ohkawa H, Sakai R, Hashimoto E, Ukai W, Saito T.
    Alcohol Clin Exp Res; 2003 Aug 01; 27(8 Suppl):64S-67S. PubMed ID: 12960510
    [Abstract] [Full Text] [Related]

  • 19. Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents.
    Coley HM, Shotton CF, Ajose-Adeogun A, Modjtahedi H, Thomas H.
    Biochem Pharmacol; 2006 Oct 16; 72(8):941-8. PubMed ID: 16934227
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.